Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

Porcelijn Leendert; Huiskes Elly; Schipperus Martin; van der Holt Bronno; de Haas Masja; Zwaginga Jaap Jan

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

【24h】

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

机译：缺乏可检测的血小板自身抗体与ITP患者中的Rituximab治疗有关

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2017年第25期|共3页
作者
Porcelijn Leendert; Huiskes Elly; Schipperus Martin; van der Holt Bronno; de Haas Masja; Zwaginga Jaap Jan;
展开▼
作者单位

Sanquin Diagnost Serv Immunohematol Diagnost Amsterdam Netherlands;

Sanquin Diagnost Serv Immunohematol Diagnost Amsterdam Netherlands;

HagaZiekenhuis Dept Internal Med The Hague Netherlands;

Haemato Oncol Fdn Adults Netherlands HOVON Dat Erasmus MC Canc Inst Clin Trial Ctr Rotterdam;

Sanquin Diagnost Serv Immunohematol Diagnost Amsterdam Netherlands;

Sanquin Res Ctr Clin Transfus Res Leiden Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients [J] . Porcelijn Leendert, Huiskes Elly, Schipperus Martin, Blood: The Journal of the American Society of Hematology . 2017,第25期

机译：缺乏可检测的血小板自身抗体与ITP患者中的Rituximab治疗有关
2. Successful Tocilizumab Treatment In A Patient With Human Herpesvirus 8-Positive And Human Immunodeficiency Virus-Negative Multicentric Castleman's Disease Of Plasma Cell Type Nonresponsive To Rituximab-CVP Therapy [J] . MuzesG., SiposF., CsomorJ., APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica . 2013,第7期

机译：利妥昔单抗-CVP治疗无反应的人疱疹病毒8阳性和人类免疫缺陷病毒阴性多中心Castleman病的浆细胞类型患者的成功的Tocilizumab治疗
3. Prediction of Response to Fostamatinib Based on the Presence of Plasma Platelet Autoantibodies in Adult Patients with Immune Thrombocytopenia - (ITP) Exploratory Analyses from Phase 3 Studies [J] . Markovtsov Vadim V., Yi Sothy, Young Chi, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：基于成人免疫血小板减少症 - （ITP）探讨分析来自第3阶段研究的成年血浆血小板自身抗体的响应对FOSTAMATINIB的反应预测
4. Successful Treatment of a Patient with High Titer Acquired Factor VIM Inhibitor (114 BU) with Rituximab [C] . Ch. Schubert, M. Herold Hemophilia Symposium . 2008

机译：用Rituximab成功治疗高滴度获得因子Vim抑制剂（114 Bu）的患者
5. Stages of change correlates for chemical abusers in out-patient treatment [D] . Katlin, Evette Nan. 2001

机译：变化的阶段与门诊治疗中的化学滥用者相关
6. Anti-platelet autoantibodies from ITP patients recognize an epitope in GPIIb/IIIa deduced by complementary hydropathy. [O] . S J De Souza, J Sabbaga, E DAmico, 1992

机译：来自ITP患者的抗血小板自身抗体识别GPIIb / IIIa中由互补性水肿引起的表位。
7. Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients [O] . Porcelijn, Leendert, Huiskes, Elly, Schipperus, Martin, 2017

机译：ITP患者缺乏可检测的血小板自身抗体与对利妥昔单抗治疗的无反应性相关

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

著录项

引文网络

相似文献

相关主题

期刊订阅